CS163564B1 - - Google Patents
Info
- Publication number
- CS163564B1 CS163564B1 CS1425A CS142573A CS163564B1 CS 163564 B1 CS163564 B1 CS 163564B1 CS 1425 A CS1425 A CS 1425A CS 142573 A CS142573 A CS 142573A CS 163564 B1 CS163564 B1 CS 163564B1
- Authority
- CS
- Czechoslovakia
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS1425A CS163564B1 (cs) | 1973-02-27 | 1973-02-27 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS1425A CS163564B1 (cs) | 1973-02-27 | 1973-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS163564B1 true CS163564B1 (cs) | 1975-09-15 |
Family
ID=5348582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS1425A CS163564B1 (cs) | 1973-02-27 | 1973-02-27 |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS163564B1 (cs) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
-
1973
- 1973-02-27 CS CS1425A patent/CS163564B1/cs unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |